Las Vegas,NV (PRWEB) May 20, 2014
Acqua Innovations, Inc. today announced the results of a successful bench scale test of the company’s pilot Solve H2O™ Treatment System to remove 1,4-dioxane from groundwater extracted from an active site.
1,4-dioxane is a solvent frequently found in contaminated groundwater at Superfund and other hazardous waste sites. It has been labeled as an “emerging contaminant” by the United States Environmental Protection Agency (EPA) due to the potential impact of the chemical on human health. The U.S. Department of Health and Human Services in its 12th report on carcinogens (June 10, 2011) identified the contaminant “as reasonably anticipated to be a human carcinogen” and identified it as a pollutant in water at sites throughout the United States. According to the EPA and the Agency for Toxic Substances and Disease Registry, in studies conducted on animals that have been exposed to high levels of 1,4-dioxane in drinking water, the chemical has been linked to cancers of the liver, nasal, and mammary gland.
Acqua Innovations’ Solve H2O™ Treatment System utilizes H2O NanoPure™, a nanoparticle based purifying agent specifically formulated to target and extract specific contaminates from polluted water. Unlike conventional water treatment methods that simply reduce the concentration of pollutants in water, H2O NanoPure™ is specifically formulated based on the attributes of the water to be treated to adsorb and extract targeted contaminates from water.
Based on water samples received from an active 1,4-dioxane treatment site, Acqua Innovations’ engineering team performed kinetic studies to customize H2O NanoPure™ to remove 1,4 dioxane from groundwater from the active site. In the bench test, contaminated water from the active site was pumped through the Solve H2O™ Treatment System’s reactor where it came into contact with the customized H2O NanoPure™ for 30 cycles in 10 minute increments. Sample readings were taken by GC-MS after 10, 20, and 30 cycles. The levels of the 1,4-dioxane were reduced from the starting point of 57.9 ppb to non-detectable concentrations. There was no degradation of H2O NanoPure™ over the course of the experiment. The same H2O NanoPure™ particles have been repeatedly utilized in laboratory tests of the Solve H2O™ Treatment System for over 6 months without loss of efficiency. Acqua Innovations’ engineers estimate that the life expectancy of these particles is 3 to 5 years, similar to synthetic media such as polystyrene resin.
“Our bench test results demonstrate that our H2O NanoPure™ treatment agent can deliver superior results for the treatment of 1,4-dioxane at significantly lower costs when compared to current treatment options,” said Meetesh Patel, CEO of Acqua Innovations. “Based on the potential of this this technology demonstrated by this test, we are in discussions with various organizations struggling with complex groundwater contamination issues in different sectors associated with water treatment and purification to field test and eventually commercially deploy the pilot Solve H2O™ Treatment System.”
The Solve H2O™ Treatment System provides industrial and municipal users with a cost-effective solution to treat, purify, and reuse water while minimizing constraints on freshwater resources. The overall value proposition of the Solve H2O™ Treatment System for customers is:
About Acqua innovations, Inc.
Acqua Innovations, Inc. is focused on developing and commercializing cutting-edge, economical and environmentally friendly smart water treatment, purification, and remediation technologies to solve today’s ever increasing water problems.
For additional information about Acqua Innovations, Inc. and our current investment opportunities, please visit http://www.acquainnovations.com
To receive future news releases via email, please visit: http://www.acquainnovations.com/contact-us/
Legal Notice Regarding Forward-Looking Statements
No statement herein should be considered an offer or a solicitation of an offer for the purchase or sale of any securities. This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although Acqua innovations, Inc. (the “Company” or Acqua Innovations”) believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, unexpected costs and operating deficits, increases in general and administrative costs, termination of contracts or agreements, technological obsolescence of the Company's products, technical problems with the Company's research and products, price increases for supplies and components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or technologies that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Company's operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Company's ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. There can be no assurance that further research and development will validate and support the results of our preliminary research and studies. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Acqua Innovations will be able to develop commercially viable products on the basis of its technologies. For more information on relating to the Company or its technologies, please visit the Company’s website (http://www.acquainnovations.com) The Company undertakes no obligation to publicly release the results of any revisions to these forward looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.